214450.KQ
214450.KQ
KR7214450009
PharmaResearch
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 536.289.118.810 350.115.068.640
53.2%
Cost of Revenue 125.071.955.760 98.877.811.420
26.5%
Gross Profit 411.217.163.050 251.237.257.220
63.7%
196.821.404.430 125.186.500.020
57.2%
Operating Income 214.395.758.620 126.050.757.200
70.1%
Pretax Income 216.513.993.290 115.812.758.330
87.0%
Net Income Common Stockholders 165.120.956.450 92.043.313.160
79.4%
-- --
--
-- --
--
ende